Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005.
Borrow
R
R
Vaccine Evaluation Unit, Health Protection Agency, Manchester Royal Infirmary, Manchester M13 9WZ, United Kingdom. ray.borrow@hpa.org.uk
Carlone
G M
GM
Rosenstein
N
N
Blake
M
M
Feavers
I
I
Martin
D
D
Zollinger
W
W
Robbins
J
J
Aaberge
I
I
Granoff
D M
DM
Miller
E
E
Plikaytis
B
B
van Alphen
L
L
Poolman
J
J
Rappuoli
R
R
Danzig
L
L
Hackell
J
J
Danve
B
B
Caulfield
M
M
Lambert
S
S
Stephens
D
D
D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood / Q000276:immunology; D000915:Antibody Affinity; D016667:Bacterial Capsules / Q000276:immunology; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology; D001770:Blood Bactericidal Activity; D002986:Clinical Trials as Topic; D006801:Humans; D022401:Meningococcal Vaccines / Q000276:immunology* / Q000592:standards*; D023421:Models, Animal; D038541:Neisseria meningitidis, Serogroup B / Q000276:immunology*; D010587:Phagocytosis; D014944:World Health Organization
D000907:Antibodies, Bacterial; D001425:Bacterial Outer Membrane Proteins; D022401:Meningococcal Vaccines